This study validates criteria to identify patients with inflammatory bowel disease (IBD) at risk of worsening disease who may benefit from early treatment with advanced therapies. Objectives: Risk ...

A "top-down" approach of early aggressive therapy for Crohn's disease continued to achieve better outcomes versus a conventional accelerated "step-up" approach, long-term follow-up data from the ...

In honor of May being ALS Awareness Month, the 37-year-old content creator has been answering viewers questions about her ...

New research suggests that progression of thyroid eye disease is not limited to the early disease period, with a number of ...

Scientists have identified a protective brain pathway that may help slow the progression of Parkinson's disease by ...

Neuraly, Inc., a wholly owned subsidiary of D&D Pharmatech, Inc. (KOSDAQ: 347850), announced that the first patient has been dosed in a Phase 2 Investigator-Initiated Trial (IIT) evaluating ...

With no known cure for Parkinson's disease, research suggests that exercise is one of the most effective ways to slow its ...

A new study identified 3 trajectories, based on projected stability, for preclinical Alzheimer disease progression.

Despite requiring substantial resources, lifestyle programs are unlikely to be successful without including a strong behavioral change component, one commenter noted.

The two treatments, Kisunla and Leqembi, have been available for about three years and have been used at other hospitals and ...

Better diabetes medications, better screening, older age at onset of DRD influence 20-year ...